X

FDA Approval of Landiolol (Rapiblyk) for Supraventricular Tachycardia

By: Nivaj Haque; PharmD Candidate c/o 2027 Recent advancements in cardiology have revolutionized the management of arrhythmias, offering new hope…

eMAR

What is the best price to use for pharmacoeconomic purposes?

By: Farzana Alam, PharmD Candidate c/o 2025, Anthony Autera, PharmD Candidate c/o 2025, Maha Saad, PharmD Background Drug pricing metrics…

eMAR

Clearing the Air: FDA Proposes to Sniff Out Phenylephrine from OTC Shelves

By: Christine Mauceri, PharmD Candidate c/o 2025 On November 7th, 2024, the Food and Drug Administration (FDA) announced its proposal…

eMAR

Oxbryta’s Journey: From Accelerated Approval to Market Withdrawal

By: Amita Singh, Pharm D Candidate c/o 2025 Voxelotor, marketed under the brand name Oxbryta, was approved by the US.…

eMAR

FDA Approves First Nasal Spray for Treatment of Anaphylaxis

By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On August 9th, 2024, the Food and Drug Administration (FDA) approved Neffy, the…

eMAR

Advancements in Fertility Treatments: IVG vs. IVF

By: Ameena Qadri PharmD Candidate c/o 2027 Advancements in reproductive technology have considerably enhanced fertility treatments, with in-vitro fertilization (IVF)…

eMAR

New York Providing Accessibility: Pharmacies Providing Hormonal Birth Control Without a Prescription

Amanda Nakhul, Biomedical Sciences c/o 2027 Reproductive rights, specifically abortion, has been a topic of contention for decades. From being…

eMAR

FDA Approves Treatment for Early Symptomatic Alzheimer’s Disease, KisunlaTM (donanemab-azbt)

By: Katelyn Hoosein, PharmD Candidate c/o 2025             Alzheimer’s disease (AD) is a neurodegenerative disorder with symptoms that progressively worsen…

eMAR

Rho Chi Talks: Dr. Hyunah Cho Leads Novel Nano-Based Optical Imaging Agent Research for Cancer Surgical Treatment Following $745,000 Grant from the NIH

By: Jennalynn Fung, PharmD candidate c/o 2025 Dr. Hyunah Cho, Ph.D., an Assistant Professor in the Department of Pharmaceutical Sciences,…

eMAR

6th Year Perspective: A Case Study on How to Best Manage Complicated Chronic Disease in Rural, Peripatetic, and Nomadic Populations

By Jennalynn Fung, PharmD Candidate c/o 2025 Introduction I’m a final year pharmacy student completing my Advanced Pharmacy Practice Rotations.…

eMAR